BCRB 2018

Validation study in locally advanced HNSCC

• Local relapse: 9/41 - No marginal recurrence (i.e. in the CTV CT

and not CTV PET )

• Regional relapse: 2/41 • Metastasis: 6/41 • Second primary: 2/41

ESTRO 2018

Grégoire & Leclerc, 2013